Monday, June 21, 2021
Home Other Serum Institute gets DCGI's approval to manufacture Russian vaccine Sputnik V in...

Serum Institute gets DCGI’s approval to manufacture Russian vaccine Sputnik V in India

Serum Institute of India (SII) will manufacture Russian vaccine Sputnik V in the country after the approval of the drug regulatory body Drug Controller General of India (DCGI). It will be manufactured at the Hadapsar facility of SII under certain conditions. The Pune-based company has tied up with Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, Moscow. On Thursday, SII had sought DCGI’s approval in this regard. The Russian vaccine needs to be given at an interval of 21 days. According to Gamaleya, two doses of Sputnik V are 91% effective while one dose is 79.4% effective.

Read more: Zee Business | Livemint | The Times Of India |

50% LikesVS
50% Dislikes

News Verification For Headline Auditors

If this seems like a news that is relevant to your industry. Would you like to verify the authenticity of the news?
Please Enter your Secret Key

We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.

Report Post

Avantika Yadav
23, Content Editor @HeadlineEnglish @HeadlineHindi